Roxadustat promotes hypoxia‐inducible factor‐1α/vascular endothelial growth factor signalling to enhance random skin flap survival in rats

Random skin flaps have limited clinical application as a broad surgical reconstruction treatment because of distal necrosis. The prolyl hydroxylase domain‐containing protein inhibitor roxadustat (RXD) enhances angiogenesis and reduces oxidative stress and inflammation. This study explored the functi...

Descripción completa

Detalles Bibliográficos
Autores principales: Lan, Qicheng, Wang, Kaitao, Meng, Zhefeng, Lin, Hang, Zhou, Taotao, Lin, Yi, Jiang, Zhikai, Chen, Jianpeng, Liu, Xuao, Lin, Yuting, Lin, Dingsheng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Blackwell Publishing Ltd 2023
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10588316/
https://www.ncbi.nlm.nih.gov/pubmed/37225176
http://dx.doi.org/10.1111/iwj.14235

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10588316/
https://www.ncbi.nlm.nih.gov/pubmed/37225176
http://dx.doi.org/10.1111/iwj.14235

Ejemplares similares